Worldwide qPCR and dPCR Markets, 2019 to 2025 - The Growth of Personalized Medicines Presents Lucrative Opportunities - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Feb 25, 2019--The “Global qPCR and dPCR Market Forecast up to 2025” report has been added to ResearchAndMarkets.com’s offering.
The global qPCR and dPCR market will grow at a CAGR of 9.2% during the forecast period.
The market has witnessed steady growth in the past few years and development in technology with the introduction of highly sensitive, robust, and reliable systems in the market. The market is fueled by rising demand for qPCR and dPCR in genetic and molecular testing, increasing private investment and funds, and increasing demand for biomarker-based tests.
The market continues to grow and is one of the most widely used technology for the quantification of nucleic acid. The advanced technology has made the device simple, fast, and accurate. Vendors are focusing towards new product launches and targeting towards end-users perspective. The majority of the revenue is generated from the leading players in the market with dominating sales of Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., Abbott Laboratories, Danaher Corporation and F. Hoffmann-La Roche Ltd.
According to analysis, North America accounted for the largest share of the global qPCR and dPCR market in 2018. The increased usage of PCR in proteomics & genomics, advanced technologies such as qPCR and PCR-based laboratory developed tests for rare genetic diseases, cancers, and infectious diseases are driving the market in North America. The Asia Pacific region is expected to witness the fastest growth rate due to large patient pool and rising healthcare expenditure.
By Product Type
In 2018, the reagents and consumables segment occupied the largest share due to its advanced features and specialty-based operations. Many companies are focusing on providing even software services. In March 2017, ThermoFisher Scientific acquired Core Informatics, a provider of cloud-based platform supporting scientific data management.
In 2018, the biomedical research accounted the maximum share followed by the clinical diagnostics. The successful completion of Human genome project has driven the growth of qPCR and dPCR market.
By Technology Type
qPCR has become the standard method for quantification of gene expression. Its high sensitivity, large dynamic range, and accuracy has led to the development of numerous applications with an increasing number of samples to be analyzed.
In 2018, academics segment gained the highest market share for qPCR and dPCR market due to increased use of technology in the field of research.
The market is dominated by North America, followed by Europe and Asia Pacific. The major share of the North America market is from the US due to the quick adoption of new and advanced technologies.
The PCR is a matured technology, innovation in the instruments, reagents, and software is essential to maintain their market position. However, this doesn’t signify lack of improvement in both instruments and reagents. Superior sensitivity, improved multiplexing, better cDNA synthesis, and greater projectivity are the major features looked upon by the end-users of the market.
Merger and acquisition have been major strategy followed by key players in the market to maintain their leadership in the market. In 2016, Thermo Fisher Scientific deployed around $5.5 billion on acquisitions. This is expected to increase the offerings and strategic positioning of the company. The company increased its Life Sciences Solutions business by acquiring Affymetrix. In early 2017, Bio-Rad Laboratories, leader in digital PCR acquired RainDance Technologies, the fastest growing company in dPCR and liquid biopsy markets.
For more information about this report visit https://www.researchandmarkets.com/research/h5vst2/worldwide_qpcr?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190225005380/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Genomics,Molecular Diagnostics
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 02/25/2019 04:56 AM/DISC: 02/25/2019 04:56 AM